Team:Bielefeld-Germany/Results/Characterization
From 2010.igem.org
(→K389011: VirA screening device) |
(→P1010: ccdB-gene) |
||
Line 34: | Line 34: | ||
- | <center> | + | <center>Table 1: Results of the transformation of the cell-death gene ''ccdB'', BioBrick <partinfo>P1010</partinfo>, into different strains of ''E. coli''. |
- | Table 1: Results of the transformation of the cell-death gene ''ccdB'', BioBrick <partinfo>P1010</partinfo>, into different strains of ''E. coli''. | + | |
{|cellpadding="10" style="border-collapse: collapse; border-width: 1px; border-style: solid; border-color: #000" | {|cellpadding="10" style="border-collapse: collapse; border-width: 1px; border-style: solid; border-color: #000" | ||
|- | |- | ||
Line 78: | Line 77: | ||
It seems that not only the gyrase mutation gyrA462 is causing a ''ccdB'' resistance. Also the gyrase mutation gyrA96 gives ''E. coli'' a ''ccdB'' resistance. This should be kept in mind when assembling BioBricks with the 3A assembly. | It seems that not only the gyrase mutation gyrA462 is causing a ''ccdB'' resistance. Also the gyrase mutation gyrA96 gives ''E. coli'' a ''ccdB'' resistance. This should be kept in mind when assembling BioBricks with the 3A assembly. | ||
- | |||
=<partinfo>K389004</partinfo>: Luciferase from pGL4.10[luc2]= | =<partinfo>K389004</partinfo>: Luciferase from pGL4.10[luc2]= |
Revision as of 14:39, 27 October 2010
<partinfo>K238008</partinfo>: virA
We wanted to use this part in our project, but could only obtain unexpected/faulty restriction patterns. Finally we chose to sequence the part, hoping to find the cause for the maintained restriction patterns. Unfortunately we could not approve the sequence of <partinfo>BBa_K238008</partinfo> deposited in the parts registry so that we chose to design our own VirA BioBrick. I strongly recommend using our VirA since it has been approved by multiple means, e.g. restriction patterns and sequencing (<partinfo>K389001</partinfo>).
<partinfo>BBa_K238011</partinfo>: vir-promoter
We made a restriction analysis and sequenced parts of this BioBrick.
<partinfo>P1010</partinfo>: ccdB-gene
The ccdB gene targets the gyrase of Escherichia coli and is lethal for all E. coli strains without the gyrase mutation gyrA462 [1]. The ccdB BioBrick is used for the 3A-assembly as a positive selection marker. We transformed this BioBrick into E. coli JM109, DH5α, TOP10, XL1-Blue, EC100D and DB3.1. E. coli JM109, XL1-Blue and DH5α seem to be ccdB resistant because there were as much colonies after P1010 transformation as observed with DB3.1. The P1010 works as expected in E. coli TOP10, EC100D (no colonies after transformation) and DB3.1 (many colonies after transformation).
E. coli strain | Resistant to ccdB? | Expected result? | Gyrase genotype [2,3] |
---|---|---|---|
DB3.1 | yes | yes | gyrA462 |
DH5α | yes | no | gyrA96 |
EC100D | no | yes | WT |
JM109 | yes | no | gyrA96 |
TOP10 | no | yes | WT |
XL1-Blue | yes | no | gyrA96 |
It seems that not only the gyrase mutation gyrA462 is causing a ccdB resistance. Also the gyrase mutation gyrA96 gives E. coli a ccdB resistance. This should be kept in mind when assembling BioBricks with the 3A assembly.
<partinfo>K389004</partinfo>: Luciferase from pGL4.10[luc2]
For a comparison between mRFP and luciferase as reporter genes click here.
Some important parameters determined by the characterization experiments are shown in tab. X. For more information concerning these experiments click on the corresponding link in tab. 2 or click here:
Table 2: Parameters for <partinfo>K389004</partinfo>.
Experiment | Result |
---|---|
Behaviour during cultivation |
|
Kinetic of luciferin conversion | max. output between 20 - 40 s |
Limit of detection (LOD) | 162 RLU ~ 0.3 % of <partinfo>J23103</partinfo> output |
Limit of quantification (LOQ) | 306 RLU ~ 0.7 % of <partinfo>J23103</partinfo> output |
<partinfo>K389011</partinfo>: VirA screening device
![](/wiki/images/0/02/Bielefeld_LD50_Graph2.jpg)
The ratio of surviving colonies ϕS was calculated like
with the number of colony forming units CFU, the concentration of kanamycin on the considered plate KanX and no kanamycin on the plate Kan0.
<partinfo>K389012</partinfo>: VirA reporter system with luciferase
coming more soon
<partinfo>K389015</partinfo>: VirA/G reporter device with luciferase
Some important parameters determined by the characterization experiments are shown in tab. X. For more information concerning these experiments click on the corresponding link in tab. X or click here:
Table X: Parameters for <partinfo>K389015</partinfo>.
Experiment | Characteristic | Value |
---|---|---|
Transfer Function | Maximum induction level | 2.2 fold |
Maximum induction level reached | 200 µM acetosyringone | |
Hill coefficient | 1.09 | |
Switch Point | 31.6 µM acetosyringone | |
Doubling time / h | without plasmid | 1.98 |
carrying K389015 | 2.24 | |
carrying K389015 with 400 µM acetosyringone | 2.67 | |
Response time | Induction: exponential phase | >1 h |
Induction: begin of cultivation | max. induction at OD600 = 1 +/- 0.5 | |
Conformation analysis | ratio ccc monomer / % | 91 |
ratio ccc dimer / % | 3.7 | |
ratio oc forms / % | 5.3 |
<partinfo>K389016</partinfo>: VirA/G reporter device with mRFP
Protocols for Cultivation and Measurement
Some important parameters determined by the characterization experiments are shown in tab. X. For more information concerning these experiments click on the corresponding link in tab. X or click here:
Table X: Parameters for <partinfo>K389016</partinfo>.
Experiment | Characteristic | Value |
---|---|---|
Transfer Function | Maximum induction level | 2.6 fold |
Maximum induction level reached | 150 µM acetosyringone | |
Hill coefficient | 1.67 | |
Switch Point | 26.5 µM acetosyringone | |
Doubling time / h | without plasmid | 1.98 |
carrying K389016 | 2.57 | |
carrying K389016 with 150 µM acetosyringone | 2.77 | |
carrying K389016 with 1000 µM acetosyringone | 3.01 | |
Conformation analysis | ratio ccc monomer / % | 91.2 |
ratio ccc dimer / % | 3.2 | |
ratio oc forms / % | 5.6 | |
Inducers | Induction by | Acetosyringone |
No Induction by | Capsaicin | |
Dopamine | ||
Homovanillic acid | ||
3-Methoxytyramine |
<partinfo>K389052</partinfo>: tightly regulated lac operon with mRFP readout
This construct was plated for plasmid isolation in a lacIq negative E. coli strain after assembly - and we have never seen such red plates when working with constructs with mRFP downstream of a promoter. This lac operon definitely shows a very high basal transcription, so it is not tightly repressed. It seems that the lacI repressor <partinfo>BBa_C0012</partinfo> is not suitable for this purpose due to its LVA degradation tag or it does not work properly. Another indicator for this assumption is the experience page of <partinfo>C0012</partinfo>.
<partinfo>K389421</partinfo>, <partinfo>K389422</partinfo>, <partinfo>K389423</partinfo>: Sensitivity Tuner amlified Vir-test system
By self designed PCR-Primer we excluded terminal GFP and the initial promoter pBAD/araC, for replacing our own VirB promotor and reporter gene luc (luciferase). Primers were designed for sensitivity tuner [http://partsregistry.org/Part:BBa_I746370 I746370], [http://partsregistry.org/Part:BBa_I746380 I746380] and [http://partsregistry.org/Part:BBa_I746390 I746390] so that standard assembly would be possible. Assembling of PCR-products took place by Silver Assembly.
Accomplishment
PCR-Primer Design
Primer forward activator phage P2:
5`-GTT TCT TCG AAT TCG CGG CCG CTT CTA GAT GTT TCA TTG TCC TTT ATG CC-3`
Primer forward activator phage PSP3:
5`-GTT TCT TCG AAT TCG CGG CCG CTT CTA GAT GAT GCA CTG CCC GTT ATG- 3`
Primer forward activator phage phi R73:
5`-GTT TCT TCG AAT TCG CGG CCG CTT CTA GAT GCG CTG CCC TTT CTG-3`
Primer backward Promotor PF from phage P2:
5`-GTT TCT TCC TGC AGC GGC CGC TAC TAG TAT TTC TCC TCT TTC TCT AGT AAG TGG- 3`
Characterization tests
Cultivation was done by induction with Acetosyringone at 50 µM. Controls were not induced Sensitivity Tuner devices as well as induced and not induced nativ system ([http://partsregistry.org/Part:BBa_K389015 K389015]; without tuning elements). Induction was done upon inoculation. Measuring point for amplification factor calculation was OD 1.0.
Results
Three sensitivity tuned Vir-Gen sensing systems were obtained: [http://partsregistry.org/Part:BBa_K389421 K389421], [http://partsregistry.org/Part:BBa_K389422 K389422] and [http://partsregistry.org/Part:BBa_K389423 K389423] distinguishing by the amplification level of luc transcription.
The amplification factor was received by apply [http://partsregistry.org/Part:BBa_K389015 K389015] as reference. Amplification calculation was done by normalizing relative luminescence units emitted from luciferase per OD. Output-signal amplification is in the induced contructs (red) [http://partsregistry.org/Part:BBa_K389422 K389422] and [http://partsregistry.org/Part:BBa_K389423 K389423] 100 and respectively 200 fold higher than in not induced controls (green). An exception is K389422 were induced and not indiced system revealed analog results. Corresponding to data of iGEM Team, Cambridge 2009, K389423 (originated from [http://partsregistry.org/Part:BBa_I746390 I746390]) shows the highest amplification rate of all tested Sensitivity Tuners. Our results indicate to higher amplification rate of [http://partsregistry.org/Part:BBa_K389421 K389421] than [http://partsregistry.org/Part:BBa_K389422 K389422] of 100 fold under induced conditions. The controls also show high basal transcription rates.
Because there is small difference in induced and not induced system visible and basal transcription rates are high, we assume that the sensitivity tuning constructs are not well applicable for luciferase measurements.
For further theory click Read out system
References
[1] http://openwetware.org/wiki/CcdB, CcdB (seen on 10.10.10).
[2] http://openwetware.org/wiki/E._coli_genotypes, E. coli genotypes (seen on 10.10.10).
[3] Metcalf, W.W. et al. (1994) Gene 138, 1.
[4] Stadler J, Lemmens R, Nyhammar T 2004, Plasmid DNA purification, The J. of Gene Medicine,Vol.6, pp.54–S66
[5] Behrens B, Eppendorf AG, Laborpraxis, Nr.20, Reinste Plasmid-DNA in nur 9 Minuten.
Canton B and Labno A (2004) [http://partsregistry.org/Part:BBa_F2620:Experience/Endy/Data_analysis Data processing of Part BBa_F2620].
Chu D, Zabet NR, Mitavskiy B (2009) [http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6WMD-4V42JG5-1&_user=10&_rdoc=1&_fmt=&_orig=search&_sort=d&_docanchor=&view=c&_acct=C000050221&_version=1&_urlVersion=0&_userid=10&md5=b6431553217aca1129c5b441f4b78425 Models of transcription factor binding: Sensitivity of activation functions to model assumptions], J Theor Biol 257(3):419-429.
Pasotti L, Zucca S, Del Fabbro E (2009) Characterization experiment on BBa_J23100, BBa_J23101, BBa_J23118, http://partsregistry.org/Part:BBa_J23101:Experience.